Counseling for transgender and gender diverse adolescents using a contraceptive
Counseling Among Gender Diverse Adolescents Who Use Depot Medroxyprogesterone
PHASE4 · University of Colorado, Denver · NCT05726903
This study is trying to find the best ways to provide contraceptive counseling for transgender and gender diverse young people who want to use a specific birth control shot called DMPA.
Quick facts
| Phase | PHASE4 |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 15 Years to 21 Years |
| Sex | Female |
| Sponsor | University of Colorado, Denver (other) |
| Locations | 1 site (Denver, Colorado) |
| Trial ID | NCT05726903 on ClinicalTrials.gov |
What this trial studies
This study focuses on developing best practices for contraceptive counseling specifically tailored for transgender and gender diverse (TGD) youth assigned female at birth who are using or interested in using depot medroxyprogesterone (DMPA). Through qualitative methods such as focus groups and semi-structured interviews, the research aims to gather insights from TGD youth about their experiences and satisfaction with DMPA. The goal is to address the unique health disparities faced by TGD youth and improve equitable access to reproductive health services. The findings will help healthcare providers create more inclusive counseling practices that consider the intersection of gender identity and reproductive health.
Who should consider this trial
Good fit: Ideal candidates for this study are transgender or gender diverse adolescents aged 15-21 who were assigned female at birth and are currently using or interested in using DMPA.
Not a fit: Patients who have contraindications to DMPA or do not identify as transgender or gender diverse may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved contraceptive counseling and reproductive health services for transgender and gender diverse youth.
How similar studies have performed: While there is limited literature on this specific approach, the study aims to fill a gap in existing research regarding equitable contraceptive counseling for TGD youth, indicating a novel focus.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * between the ages of 15-21, * currently receiving care at one of the clinic sites, assigned female at birth, identify as transgender or gender diverse , and are currently using or are interested in using DMPA. Exclusion Criteria: * Any contraindications to DMPA (based on any category 3 or 4 recommendations from the CDC MEC guidelines)
Where this trial is running
Denver, Colorado
- Comprehensive Women's Health Center — Denver, Colorado, United States (RECRUITING)
Study contacts
- Study coordinator: Nancy Z Fang, MD
- Email: NANCY.FANG@CUANSCHUTZ.EDU
- Phone: 3037248482
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Gender Dysphoria, Adolescent